NCT03446547
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03446547
Title Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736) (ASTEROID)
Acronym ASTEROID
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vastra Gotaland Region
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE | NOR | FIN

Facility Status City State Zip Country Details
Helsinki Helsinki Finland Details
Dept of Oncology Tampere Finland Details
Turku Turku Finland Details
Dept of Oncology Vaasa Finland Details
Ålesund Ålesund Norway Details
Dept of Oncology Oslo Norway Details
Dept of pulmonary medicine Tromsø Norway Details
Dept of Oncology Trondheim Norway Details
Dept of pulmonary medicine Gävle Sweden Details
Dept. of Oncology Gothenburg Sweden Details
Dept of pulmonary medicine Linköping Sweden Details
Sunderbyn Luleå Sweden Details
Dept of pulmonary medicine Lund Sweden Details
Dept of Oncology Stockholm Sweden Details
Dept. of Oncology Umeå Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field